Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01681498 · ClinicalTrials.gov registry record
Fetal Electrocardiogram Extraction-Pilot Study
A clinical trial, sponsored by Huntleigh Healthcare.
- Terminated
- Registry status
- 20
- Enrollment target
NCT01681498: Clinical Trial study, sponsored by Huntleigh Healthcare.
NCT01681498 is a clinical trial that was terminated before completion, run by Huntleigh Healthcare. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01681498 was terminated before completion, sponsored by Huntleigh Healthcare.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is a pilot study utilizing trans-abdominal ECG and Doppler Ultrasounds to assess the feasibility of extracting fECGs in a volunteer population.
Primary Outcome
Beat-to-beat fetal heart rate will be compared to the Doppler result using Pearson Correlation. Timing of PR, QT, and QS, if visible, will be compared with published normative values from the neonatology literature as these values are not otherwise obtainable in an ongoing pregnancy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-05 |
Why NCT01681498 stopped before completion
NCT01681498 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01681498 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01681498 about?
NCT01681498 is a clinical study titled "Fetal Electrocardiogram Extraction-Pilot Study". This is a pilot study utilizing trans-abdominal ECG and Doppler Ultrasounds to assess the feasibility of extracting fECGs in a volunteer population.
What is the current status of trial NCT01681498?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2013-05. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT01681498?
This trial is sponsored by Huntleigh Healthcare, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia